Home

How the XETA test is transforming testing for endocrine disruption

22nd October 2020

By Maria Meinerling, Head Of Scientific and Technological Innovation, Vice Head of Test Facility - Assessing and testing chemicals for their endocrine potential is scientifically demanding and requires both specific expertise and high-tech laboratories. The whole process can take considerable time and financial investment. With chemicals that cause endocrine effects outlawed in Europe, the outcome of such tests is crucial for our clients. For plant protection products the outcome can lead to the discontinuation of entire product lines.  

At ibacon we are particularly enthused by the new XETA test which is transforming the approach to the testing of endocrine disrupters. We believe it is a highly valuable progression for both manufacturers and users of chemicals. Not only does the XETA test enable them to speed-up the whole testing and results process, it also represents a strong step forward with regard to the three R’s of animal testing - replacement, reduction and refinement... 

 If you want to read more, click on the download button below